发明名称 Unit dosage forms for the treatment of herpes simplex
摘要 The components of this invention are chosen because of their complementarity for the prevention or treatment of diseases caused by the herpes simplex virus. L-Lysine favorably increases the physiologic immunomodulation necessary for defense against this virus. Zinc improves and maintains a normal immune response. 2-Deoxy-2-D-glucose and heparin sodium alter the surface interaction between the herpes virus and the cell, preventing fusion and infectivity. N-Acetyl-L-cysteine increases glutathione levels thereby creating a thiol redox barrier to the virus at the cell membrane. Quercetin reduces intracellular replication of the herpes virus and viral infectivity. Ascorbate, in concert with copper and D-alpha-tocopherol, provides an antioxidant defense against the herpes virus, which tends to lose latency during period of oxidative, free radical excess. Selenium and quercetin also participate in reducing various oxidative stresses. Together the components of this invention provide the potential for improved resistance to, improved recovery from, and a decreased frequency of recurrence of herpes simplex virus infection.
申请公布号 US6455061(B2) 申请公布日期 2002.09.24
申请号 US20010828323 申请日期 2001.04.05
申请人 CHRONORX, LLC 发明人 RICHARDSON KENNETH T.;PEARSON DON C.
分类号 A61K9/00;A61K9/06;A61K9/22;A61K9/24;A61K33/34;A61K45/06;(IPC1-7):A61F13/00;A61F2/00;A61K35/56;A61K35/36 主分类号 A61K9/00
代理机构 代理人
主权项
地址